Thu, September 19, 2024

Matthew Biegler Maintained (TYRA) at Buy with Increased Target to $33 on, Sep 19th, 2024

Matthew Biegler of Oppenheimer, Maintained "Tyra Biosciences, Inc." (TYRA) at Buy with Increased Target from $25 to $33 on, Sep 19th, 2024.

Matthew has made no other calls on TYRA in the last 4 months.



There are 3 other peers that have a rating on TYRA. Out of the 3 peers that are also analyzing TYRA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $33 on, Thursday, August 15th, 2024
  • Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $28 on, Thursday, August 8th, 2024
  • Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Wednesday, July 3rd, 2024